GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00328364 | Thyroid | PTC | glomerular basement membrane development | 9/5968 | 11/18723 | 9.49e-04 | 5.70e-03 | 9 |
GO:00720067 | Thyroid | PTC | nephron development | 61/5968 | 142/18723 | 3.49e-03 | 1.69e-02 | 61 |
GO:00328356 | Thyroid | PTC | glomerulus development | 29/5968 | 62/18723 | 9.96e-03 | 4.07e-02 | 29 |
GO:003158928 | Thyroid | ATC | cell-substrate adhesion | 195/6293 | 363/18723 | 1.58e-15 | 1.17e-13 | 195 |
GO:001081029 | Thyroid | ATC | regulation of cell-substrate adhesion | 128/6293 | 221/18723 | 8.74e-14 | 4.57e-12 | 128 |
GO:0007160111 | Thyroid | ATC | cell-matrix adhesion | 128/6293 | 233/18723 | 1.49e-11 | 5.41e-10 | 128 |
GO:003019812 | Thyroid | ATC | extracellular matrix organization | 152/6293 | 301/18723 | 8.63e-10 | 2.24e-08 | 152 |
GO:004306212 | Thyroid | ATC | extracellular structure organization | 152/6293 | 302/18723 | 1.17e-09 | 2.94e-08 | 152 |
GO:004522912 | Thyroid | ATC | external encapsulating structure organization | 152/6293 | 304/18723 | 2.11e-09 | 5.08e-08 | 152 |
GO:0010811210 | Thyroid | ATC | positive regulation of cell-substrate adhesion | 73/6293 | 123/18723 | 4.12e-09 | 9.37e-08 | 73 |
GO:000182222 | Thyroid | ATC | kidney development | 146/6293 | 293/18723 | 5.81e-09 | 1.28e-07 | 146 |
GO:000165522 | Thyroid | ATC | urogenital system development | 164/6293 | 338/18723 | 7.92e-09 | 1.70e-07 | 164 |
GO:007200122 | Thyroid | ATC | renal system development | 149/6293 | 302/18723 | 9.48e-09 | 1.99e-07 | 149 |
GO:0045785210 | Thyroid | ATC | positive regulation of cell adhesion | 194/6293 | 437/18723 | 1.40e-06 | 1.75e-05 | 194 |
GO:007200614 | Thyroid | ATC | nephron development | 69/6293 | 142/18723 | 1.50e-04 | 1.04e-03 | 69 |
GO:007171113 | Thyroid | ATC | basement membrane organization | 20/6293 | 31/18723 | 4.20e-04 | 2.51e-03 | 20 |
GO:003283512 | Thyroid | ATC | glomerulus development | 31/6293 | 62/18723 | 5.52e-03 | 2.24e-02 | 31 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NID1 | SNV | Missense_Mutation | novel | c.724N>A | p.Asp242Asn | p.D242N | P14543 | protein_coding | tolerated(0.18) | benign(0.038) | TCGA-3C-AALI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Poly E | Complete Response |
NID1 | SNV | Missense_Mutation | rs765670423 | c.1219G>A | p.Ala407Thr | p.A407T | P14543 | protein_coding | tolerated(0.4) | benign(0) | TCGA-A2-A0CP-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD |
NID1 | SNV | Missense_Mutation | rs765549848 | c.520N>C | p.Gly174Arg | p.G174R | P14543 | protein_coding | tolerated(0.28) | benign(0.011) | TCGA-A8-A06X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
NID1 | SNV | Missense_Mutation | | c.1074G>C | p.Glu358Asp | p.E358D | P14543 | protein_coding | tolerated(0.27) | benign(0.003) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
NID1 | SNV | Missense_Mutation | | c.766N>A | p.Gly256Arg | p.G256R | P14543 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-AN-A0G0-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
NID1 | SNV | Missense_Mutation | | c.952N>G | p.Leu318Val | p.L318V | P14543 | protein_coding | tolerated(0.45) | benign(0) | TCGA-AO-A0J6-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
NID1 | SNV | Missense_Mutation | rs771262101 | c.2423N>A | p.Pro808Gln | p.P808Q | P14543 | protein_coding | tolerated(0.6) | benign(0.003) | TCGA-AR-A1AY-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unspecific | Doxorubicin | SD |
NID1 | SNV | Missense_Mutation | | c.388A>G | p.Ile130Val | p.I130V | P14543 | protein_coding | tolerated(1) | benign(0) | TCGA-AR-A24Q-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
NID1 | SNV | Missense_Mutation | novel | c.2639N>A | p.Ala880Glu | p.A880E | P14543 | protein_coding | tolerated(1) | benign(0.001) | TCGA-B6-A40C-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | cyclophosphamide | SD |
NID1 | SNV | Missense_Mutation | rs202192927 | c.326N>T | p.Ala109Val | p.A109V | P14543 | protein_coding | tolerated(0.08) | benign(0.067) | TCGA-BH-A0HA-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |